Skip to main content
    I

    Indaptus Therapeutics Inc (INDP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.45
    +0.28 (+8.83%)

    Market Cap: $422.38M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Indaptus Therapeutics Inc (INDP) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Indaptus Therapeutics are Avalo Therapeutics (AVTX), Candel Therapeutics (CADL) and Century Therapeutics (IPSC). By market cap, Indaptus Therapeutics ranks 8th of the 13 companies on this page; OmniAb (OABI) is the largest at $716.17M.

    Peer Comparison

    INDP's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Indaptus Therapeutics (INDP)$422.38MN/AN/A0.0%N/A0.0%0.00%
    Avalo Therapeutics Inc (AVTX)$448.71MN/AN/A0.0%N/A-69.3%0.00%
    Candel Therapeutics Inc (CADL)$486.37MN/AN/A0.0%-43.5%0.0%0.00%
    Century Therapeutics Inc (IPSC)$299.63MN/AN/A0.0%N/A-100.0%0.00%
    Surrozen Inc (SRZN)$602.54MN/A36.1x0.0%N/A408.6%0.00%
    Kyverna Therapeutics, Inc. Common Stock (KYTX)$319.27MN/AN/A0.0%-81.5%0.0%0.00%
    Immuneering Corp (IMRX)$240.27MN/AN/A0.0%N/A-99.8%0.00%
    Immix Biopharma Inc (IMMX)$657.09MN/AN/A0.0%-14.9%0.0%0.00%
    Prelude Therapeutics Inc (PRLD)$275.32MN/A16.3x-269.7%N/A41.0%0.00%
    OmniAb Inc. (OABI)$716.17MN/A15.7x-108.1%-17.5%78.3%0.00%
    Tectonic Therapeutic, Inc. (TECX)$413.27MN/AN/A0.0%N/A0.0%0.00%
    Shattuck Labs Inc (STTK)$473.57MN/AN/A0.0%N/A-66.6%0.00%
    Gyre Therapeutics Inc. (GYRE)$471.74MN/A3.8x-22.7%N/A0.7%0.00%
    Peer median$460.22MN/A16.0x0.0%-30.5%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Indaptus Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Avalo Therapeutics Inc (AVTX)
    Avalo Therapeutics Inc is a forward-thinking clinical-stage biotechnology company focused on developing transformative therapies for rare and underserved...
    AVTX competitors
    Candel Therapeutics Inc (CADL)
    Candel Therapeutics Inc. is a pioneering biotechnology company focused on revolutionizing cancer treatment through its proprietary oncolytic virus platform...
    CADL competitors
    Century Therapeutics Inc (IPSC)
    Century Therapeutics Inc. (Ticker: IPSC) is a leading biotechnology company specializing in allogenic cell therapy...
    IPSC competitors
    Surrozen Inc (SRZN)
    Surrozen Inc. is a clinical-stage biopharmaceutical company at the forefront of developing innovative therapeutics using its proprietary SIRPa-IgG platform...
    SRZN competitors
    Kyverna Therapeutics, Inc. Common Stock (KYTX)
    Kyverna Therapeutics, Inc. is an innovative biotechnology company focused on advancing immunotherapies for autoimmune diseases and other significant health...
    KYTX competitors
    Immuneering Corp (IMRX)
    Immuneering Corp (IMRX) is a cutting-edge biotechnology firm dedicated to advancing targeted therapeutics for cancer and other critical illnesses through its...
    IMRX competitors
    Immix Biopharma Inc (IMMX)
    Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology...
    IMMX competitors
    Prelude Therapeutics Inc (PRLD)
    Prelude Therapeutics Incorporated, a precision clinical-stage oncology company, focuses on the discovery and development of small molecule therapies optimized...
    PRLD competitors
    OmniAb Inc. (OABI)
    OmniAb Inc. is an innovative biotechnology company dedicated to the development of fully human therapeutic antibodies via its advanced OmniAb platform.
    OABI competitors
    Tectonic Therapeutic, Inc. (TECX)
    Tectonic Therapeutic, Inc. engages in the discovery of antibodies and other biologic drugs targeting G-protein-coupled receptors (GPCRs) to develop novel...
    TECX competitors
    Shattuck Labs Inc (STTK)
    Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapies for the treatment of cancer and autoimmune diseases in the United States.
    STTK competitors
    Gyre Therapeutics Inc. (GYRE)
    Gyre Therapeutics Inc. is a pioneering biopharmaceutical company at the forefront of developing advanced therapies for rare and complex diseases.
    GYRE competitors

    Frequently Asked Questions About INDP

    Who are Indaptus Therapeutics' main competitors?

    The companies most similar to Indaptus Therapeutics include Avalo Therapeutics (AVTX), Candel Therapeutics (CADL), Century Therapeutics (IPSC), Surrozen (SRZN) and Kyverna Therapeutics, Inc. Common Stock (KYTX), listed from the closest match.

    Who is Indaptus Therapeutics' biggest competitor?

    OmniAb (OABI) is the largest of the similar companies at $716.17M; Avalo Therapeutics (AVTX) is the closest match by business profile, size, sector and industry.

    How does INDP stock compare with its competitors?

    INDP's net margin is 0.0% against a peer median of 0.0%.

    Which of Indaptus Therapeutics' competitors pays a higher dividend?

    Indaptus Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Indaptus Therapeutics bigger than its competitors?

    No. Indaptus Therapeutics is 8th by market cap among the 13 companies on this page; the largest is OmniAb (OABI) at $716.17M.